{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:09:34Z","timestamp":1791864574436,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.2215\/cjn.11951113","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:24:21Z","timestamp":1397175861000},"page":"1033-1039","source":"Crossref","is-referenced-by-count":68,"title":["IgA Nephropathy with Minimal Change Disease"],"prefix":"10.2215","volume":"9","author":[{"given":"Leal C.","family":"Herlitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Bomback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivette D.","family":"D\u2019Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230601","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2215\/CJN.04351206","article-title":"Idiopathic IgA nephropathy: Pathogenesis, histopathology, and therapeutic options.","volume":"2","author":"Tumlin","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-7-20230601","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","article-title":"Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome.","volume":"24","author":"D\u2019Amico","year":"2004","journal-title":"Semin Nephrol"},{"key":"R3-7-20230601","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/sj.ki.5000419","article-title":"Treatment of IgA nephropathy.","volume":"69","author":"Barratt","year":"2006","journal-title":"Kidney Int"},{"key":"R4-7-20230601","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0272-6386(89)80168-4","article-title":"Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: Disappearance of mesangial IgA deposits following steroid-induced remission.","volume":"14","author":"Cheng","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R5-7-20230601","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000168050","article-title":"Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: A report of an older patient and review of the literature.","volume":"10","author":"Clive","year":"1990","journal-title":"Am J Nephrol"},{"key":"R6-7-20230601","first-page":"205","article-title":"Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.","volume":"6","author":"Furuse","year":"1985","journal-title":"Int J Pediatr Nephrol"},{"key":"R7-7-20230601","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.3346\/jkms.2009.24.S1.S44","article-title":"Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome.","volume":"24","author":"Kim","year":"2009","journal-title":"J Korean Med Sci"},{"key":"R8-7-20230601","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/ajcp\/86.6.716","article-title":"An overlapping syndrome of IgA nephropathy and lipoid nephrosis.","volume":"86","author":"Lai","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"R9-7-20230601","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0272-6386(85)80120-7","article-title":"Mesangial IgA deposits with steroid responsive nephrotic syndrome: Probable minimal lesion nephrosis.","volume":"5","author":"Sinnassamy","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"R10-7-20230601","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5414\/CNP65203","article-title":"Mesangial IgA deposition in minimal change nephrotic syndrome: Coincidence of different entities or variant of minimal change disease?","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"key":"R11-7-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000167070","article-title":"Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: A separate entity? Observation of two cases.","volume":"6","author":"Barbiano di Belgiojoso","year":"1986","journal-title":"Am J Nephrol"},{"key":"R12-7-20230601","first-page":"98","article-title":"Steroid-dependent nephrotic syndrome with minimal glomerular changes and mesangial IgA deposits.","volume":"9","author":"Gallego","year":"1988\u20131989","journal-title":"Child Nephrol Urol"},{"key":"R13-7-20230601","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000184489","article-title":"Mesangial IgA nephropathy and idiopathic nephrotic syndrome.","volume":"47","author":"Rambausek","year":"1987","journal-title":"Nephron"},{"key":"R14-7-20230601","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(85)80148-7","article-title":"Spontaneous remission of nephrotic syndrome in IgA glomerular disease.","volume":"6","author":"Wu","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"R15-7-20230601","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10157-011-0580-4","article-title":"A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.","volume":"16","author":"Hirose","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"R16-7-20230601","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5414\/CN107682","article-title":"Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.","volume":"79","author":"Qin","year":"2013","journal-title":"Clin Nephrol"},{"key":"R17-7-20230601","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/ndt\/gft211","article-title":"Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: A single-centre cohort study.","volume":"28","author":"Wang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R18-7-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: Clinical characteristics, treatment, and outcomes.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-7-20230601","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","article-title":"Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial.","volume":"53","author":"Lv","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R20-7-20230601","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: A randomised controlled trial.","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"key":"R21-7-20230601","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2011111112","article-title":"Corticosteroid therapy in IgA nephropathy.","volume":"23","author":"Lv","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R22-7-20230601","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification.","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"R23-7-20230601","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility.","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"R25-7-20230601","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3476(84)80479-5","article-title":"A simple estimate of glomerular filtration rate in full-term infants during the first year of life.","volume":"104","author":"Schwartz","year":"1984","journal-title":"J Pediatr"},{"key":"R26-7-20230601","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(12)80260-5","article-title":"Mechanisms of proteinuria in noninflammatory glomerular diseases.","volume":"21","author":"Savin","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R27-7-20230601","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.","volume":"79","author":"El Karoui","year":"2011","journal-title":"Kidney Int"},{"key":"R28-7-20230601","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2010.466","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.","volume":"79","author":"Hill","year":"2011","journal-title":"Kidney Int"},{"key":"R29-7-20230601","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CNP57120","article-title":"Minimal change disease in systemic lupus erythematosus.","volume":"57","author":"Dube","year":"2002","journal-title":"Clin Nephrol"},{"key":"R30-7-20230601","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/ajkd.2002.36875","article-title":"SLE and idiopathic nephrotic syndrome: Coincidence or not?","volume":"40","author":"Hertig","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R31-7-20230601","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus.","volume":"16","author":"Kraft","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R32-7-20230601","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfq559","article-title":"Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.","volume":"26","author":"Han","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R33-7-20230601","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2215\/CJN.04820511","article-title":"Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.","volume":"7","author":"Kim","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-7-20230601","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000167603","article-title":"Minimal-change glomerulopathy of adulthood.","volume":"8","author":"Korbet","year":"1988","journal-title":"Am J Nephrol"},{"key":"R35-7-20230601","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy.","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R36-7-20230601","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","article-title":"Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.","volume":"39","author":"Nakayama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R37-7-20230601","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: A long-term follow-up.","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"key":"R38-7-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations.","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"R39-7-20230601","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial.","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201406000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:20Z","timestamp":1786369460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201406000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11951113","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}